Patents by Inventor Hidenao Fukushima

Hidenao Fukushima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RISPERIDONE-CONTAINING TRANSDERMAL PREPARATION AND ADHESIVE PATCH USING SAME
    Publication number: 20120052112
    Abstract: A transdermal preparation is provided that contains risperidone and/or a pharmaceutically acceptable salt thereof as a drug, and the amount of the drug is 1 to 20 parts by mass based on 100 parts by mass of the total mass of the preparation. The skin permeation rate of the preparation is 0.5 to 30 ?g/cm2/hour, and the drug diffusion coefficient of the preparation in the skin is 1.2×10?6 to 10.0×10?6 cm/hour.
    Type: Application
    Filed: February 19, 2010
    Publication date: March 1, 2012
    Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
    Inventors: Mitsuru Kuribayashi, Motohiro Suzuki, Hidenao Fukushima, Eisuke Shimizu
  • Novel medicament for treating neurodegenerative diseases
    Publication number: 20070249534
    Abstract: A medicament for treating neurodegenerative diseases, comprising as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from the C-terminal of selenoprotein P. An excellent medicament for treating neurodegenerative diseases, especially suitable for treating neurodegenerative diseases with ataxia as a principal symptom is provided.
    Type: Application
    Filed: February 20, 2007
    Publication date: October 25, 2007
    Inventors: Masaki Hirashima, Takeshi Naruse, Hiroaki Maeda, Chikateru Nozaki, Takeshi Goto, Katsuhiko Akiyama, Hidenao Fukushima
  • Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof
    Publication number: 20060058398
    Abstract: To provide medicinal compositions containing an active ingredient which has a low molecular weight, is free from any side effects and has an effect of potentiating nerve growth factor activity and utilization thereof for treating diseases associated with dementia, medicinal preparations containing an effective amount of vitamin K and/or its derivative showing an effect of potentiating nerve growth factor activity are provided.
    Type: Application
    Filed: January 24, 2003
    Publication date: March 16, 2006
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Yuto Kamei, Takeshi Goto, Hidenao Fukushima, Kengo Uemura
  • Nerve growth factor activity potentiating agents
    Publication number: 20050192343
    Abstract: Agents potentiating nerve growth factor activity are provided for treating Alzheimer's disease which contain as the active ingredient dodecatrienoic acid derivatives represented by the general formula (I): wherein X represents hydrogen, CHO, COOH, COOR (wherein R represents an ester residue or an addition salt comprising an alkali metal salt or an organic acid salt group), provided that in case where X is COOH, it is bonded to the carbon atom at the position marked with * so as to form a lactam O?C—O—.
    Type: Application
    Filed: May 3, 2005
    Publication date: September 1, 2005
    Inventors: Takeshi Goto, Toshio Itoyama, Hidenao Fukushima, Yuto Kamei
  • Novel remedies for neurodegenerative disease
    Publication number: 20050143310
    Abstract: A medicament for treating neurodegenerative diseases, comprising as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from the C-terminal of selenoprotein P. An excellent medicament for treating neurodegenerative diseases, especially suitable for treating neurodegenerative diseases with ataxia as a principal symptom is provided.
    Type: Application
    Filed: May 10, 2002
    Publication date: June 30, 2005
    Inventors: Masaki Hirashima, Takeshi Naruse, Hiroaki Maeda, Chikateru Nozaki, Takeshi Goto, Katsuhiko Akiyama, Hidenao Fukushima
  • Morphan derivatives or salts thereof and medicinal compositions containing the same
    Patent number: 6608080
    Abstract: Medicinal compositions having an effect of regulating the activation of glycine receptor and novel morphan derivatives. Medicinal compositions comprising morphan derivatives or its salts and a pharmaceutically acceptable carrier. These compositions potentiate or inhibit the activation of glycine receptor, which makes them useful as drugs for the central nervous system. Novel 1- and/or 2-substituted morphan derivatives (2-azabicyclo[3.3.1]nonane derivatives) or salts thereof.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: August 19, 2003
    Assignee: Hisamitsu Pharmaceutical Co., Ltd.
    Inventors: Chihiro Kibayashi, Takeshi Miyata, Kazuo Takahama, Hidenao Fukushima
  • Nerve growth factor activity potentiating agents
    Publication number: 20030068330
    Abstract: Agents potentiating nerve growth factor activity are provided for treating Alzheimer's disease which contain as the active ingredient dodecatrienoic acid derivatives represented by the general formula (I): 1
    Type: Application
    Filed: August 7, 2002
    Publication date: April 10, 2003
    Inventors: Takeshi Goto, Toshio Itoyama, Hidenao Fukushima, Yuto Kamei